143
Publications
25K
Citations
73
H-Index
1979
Active since
David E. Moller is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and diabetes.
Top concepts
MedicinePharmacologyDiabetesMetabolic SyndromeBiochemistryHealthPhysiologyEndocrinologyMetabolismCell Biology
Publications per year
1979–2023
143
143
Role of AMP-activated protein kinase in mechanism of metformin action
Gaochao Zhou, Robert P. Myers, Ying Li et al. · Journal of Clinical Investigation · 2001 · 5.3K citations
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Tamer Coşkun, Holly A. Bina, M. Schneider et al. · Endocrinology · 2008 · 1K citations
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gregory Gaich, Jenny Y. Chien, Haoda Fu et al. · Cell Metabolism · 2013 · 867 citations · Full text
Rows per page
1–5 of 143